09/2009 - Državni zavod za intelektualno vlasništvo

3552 HR - Patenti - Hrvatski glasnik intelektualnog vlasništva 16, 2009, 9, 3373 – 3601
Podnositelj europske MKP Broj objave europske Naziv izuma
prijave patenta
prijave patenta
(71) (51) (97) (54)
ISHIHARA SANGYO KAISHA, LTD., JP A01N 43/56 (2006.01)
EP 2094087 * PESTICIDAL COMPOSITIONS
A01N 43/40 (2006.01)
A01N 55/04 (2006.01)
A01P 7/00 (2006.01)
A01N 47/34 (2006.01)
A01N 43/90 (2006.01)
A01P 3/00 (2006.01)
A01N 51/00 (2006.01)
A01N 43/58 (2006.01)
A01N 57/32 (2006.01)
A01N 43/22 (2006.01)
A01N 47/40 (2006.01)
A01N 37/28 (2006.01)
Istituto di Ricerche di Biologia C07D 498/08 (2006.01)
EP 2086982 * HCV NS3 PROTEASE INHIBITORS
Molecolare P. Angeletti, IT
C07D 498/18 (2006.01)
C07K 5/08 (2006.01)
C07K 5/10 (2006.01)
C07K 5/12 (2006.01)
A61K 31/40 (2006.01)
A61K 38/06 (2006.01)
A61K 38/07 (2006.01)
A61K 31/12 (2006.01)
Istvan, Rudyard, US A61K 31/201 (2006.01)
EP 2091528 * METHODS OF INACTIVATING VIRUSES
J. Eberspächer GmbH & Co. KG, DE F23D 3/40 (2006.01) EP 1662199 Evaporator and process for fabricating same
J. Eberspächer GmbH & Co. KG, DE F24H 3/06 (2006.01) EP 1681519 Heat exchanger and vehicle heater having such a heat
JANSSEN PHARMACEUTICA N.V., BE C07D 215/22 (2006.01)
A61K 31/47 (2006.01)
A61P 31/06 (2006.01)
EP 2086940 *
JANSSEN PHARMACEUTICA N.V., BE C07D 215/22 (2006.01)
EP 2086941 *
A61K 31/465 (2006.01)
A61P 31/06 (2006.01)
JANSSEN PHARMACEUTICA N.V., BE A61K 31/165 (2006.01)
EP 2089011 *
A61P 25/00 (2006.01)
A61P 25/18 (2006.01)
A61P 25/24 (2006.01)
JANSSEN PHARMACEUTICA N.V., BE G01N 33/50 (2006.01)
EP 2089710 *
G01N 33/68 (2006.01)
C12Q 1/48 (2006.01)
JANSSEN PHARMACEUTICA N.V., BE C07D 401/12 (2006.01)
EP 2091938 *
A61K 31/501 (2006.01)
A61P 25/18 (2006.01)
JANSSEN PHARMACEUTICA N.V., BE C07D 401/12 (2006.01)
EP 2091942 *
C07D 241/20 (2006.01)
A61K 31/501 (2006.01)
A61P 25/00 (2006.01)
JANSSEN PHARMACEUTICA N.V., BE C07D 307/80 (2006.01)
EP 2097399 *
C07D 307/81 (2006.01)
A61K 31/343 (2006.01)
JANSSEN PHARMACEUTICA N.V., BE C07D 215/14 (2006.01)
EP 2099758 *
C07D 401/04 (2006.01)
C07D 413/04 (2006.01)
C07D 417/04 (2006.01)
A61K 31/496 (2006.01)
A61P 31/04 (2006.01)
JANSSEN PHARMACEUTICA N.V., BE C07D 215/14 (2006.01)
EP 2099759 *
C07D 401/04 (2006.01)
C07D 413/04 (2006.01)
C07D 417/04 (2006.01)
A61K 31/496 (2006.01)
A61P 31/04 (2006.01)
JANSSEN PHARMACEUTICA N.V., BE C07D 215/22 (2006.01)
EP 2099760 *
C07D 401/06 (2006.01)
C07D 401/10 (2006.01)
C07D 405/06 (2006.01)
C07D 405/10 (2006.01)
C07D 409/10 (2006.01)
A61K 31/435 (2006.01)
A61P 31/00 (2006.01)
exchanger
FUMARATE SALT OF (ALPHA S, BETA R)-6-BROMO-
ALPHA-[2-(DIMETHYLAMINO)ETHYL]-2-METHOXY-
ALPHA-1-NAPHTHALENYL-BETA-PHENYL-3-
QUINOLINEETHANOL
ANTIBACTERIAL QUINOLINE DERIVATIVES
TREATMENT OF PERVASIVE DEVELOPMENTAL
DISORDERS
A METHOD FOR PHARMACOLOGICALLY PROFILING
COMPOUNDS
PIPERIDINYLAMINO-PYRIDAZINES AND THEIR USE
AS FAST DISSOCIATING DOPAMINE 2 RECEPTOR
ANTAGONISTS
SUBSTITUTED PYRAZINONE DERIVATIVES FOR
USE AS A MEDICINE
NOVEL INHIBITORS OF CHYMASE
ANTIBACTERIAL QUINOLINE DERIVATIVES
ANTIBACTERIAL QUINOLINE DERIVATIVES
ANTIBACTERIAL QUINOLINE DERIVATIVES
ISSN 1331-2030